• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全面分析 CDCAs 在头颈部鳞状细胞癌中的表达和预后。

Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.

机构信息

Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

出版信息

PLoS One. 2020 Jul 27;15(7):e0236678. doi: 10.1371/journal.pone.0236678. eCollection 2020.

DOI:10.1371/journal.pone.0236678
PMID:32716971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7384661/
Abstract

Head and neck squamous cell carcinoma (HNSCC), a tumor included oral cavity, lips, larynx, oropharynx, and the nasopharynx et al. The cell division cycle-associated (CDCA) protein family (CDCA1-8) critical for normal cell function and cancer cell proliferation. We explored the mutation signatures and expression levels of various CDCAs in detail in HNSCC. A comprehensive bioinformatics analysis pipeline based on copy number and gene expressions data from patients with HNSCC in order to given new insights into the possible functions and distinct prognostics that underlie CDCAs regulation. We compared the transcriptional expression of CDCAs in HNSCC and found significantly elevated mRNA expression of CDCA1-8 in HNSCC tissues across multiple datasets. We also found CDCA5/6/8 are over-expressed both transcriptionally and translationally in patients with HNSCC. Our results suggested that that mRNA levels of CDCA1/2/4/7 related to the prognosis and can be used as a new useful biomarker for predicting the survival of HNSCC patients. The top 5 CDCAs neighboring gene alterations in HNSCCs were found in MYC, STAG1, RAD21, KLHL9 and NDC80. Multivariable Cox proportional hazard model also showed that CD8+ T cells were higher (P<0.05) in HNSCC-HPV-pos patients and that this was related to CDCA1/2/3/4/5/7. This study utilizes online tools to conduct specific gene analyses from free open databases, but our study requires more large-scale genomics research and basic research.

摘要

头颈部鳞状细胞癌(HNSCC)是一种包括口腔、嘴唇、喉、口咽和鼻咽等部位的肿瘤。细胞分裂周期相关(CDCA)蛋白家族(CDCA1-8)对正常细胞功能和癌细胞增殖至关重要。我们详细研究了 HNSCC 中各种 CDCAs 的突变特征和表达水平。基于 HNSCC 患者的拷贝数和基因表达数据,我们建立了一个全面的生物信息学分析管道,以深入了解 CDCAs 调节的可能功能和独特预后。我们比较了 HNSCC 中 CDCAs 的转录表达,发现多个数据集的 HNSCC 组织中 CDCA1-8 的 mRNA 表达显著升高。我们还发现 CDCA5/6/8 在 HNSCC 患者中无论是转录还是翻译都过度表达。我们的研究结果表明,CDCA1/2/4/7 的 mRNA 水平与预后相关,可作为预测 HNSCC 患者生存的新的有用生物标志物。在 HNSCC 中发现了前 5 位与 CDCAs 相邻的基因改变,分别为 MYC、STAG1、RAD21、KLHL9 和 NDC80。多变量 Cox 比例风险模型还显示,HPV 阳性的 HNSCC 患者中 CD8+T 细胞更高(P<0.05),这与 CDCA1/2/3/4/5/7 有关。本研究利用在线工具从免费开放数据库中进行特定基因分析,但我们的研究需要更多大规模的基因组学研究和基础研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/cec01d18bb19/pone.0236678.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/f1e026add4a2/pone.0236678.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/ab6ba556824d/pone.0236678.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/223db8b66b20/pone.0236678.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/2e877bd18fe3/pone.0236678.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/b9260a9c7159/pone.0236678.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/a8a091181610/pone.0236678.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/ca729a4c0499/pone.0236678.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/cec01d18bb19/pone.0236678.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/f1e026add4a2/pone.0236678.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/ab6ba556824d/pone.0236678.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/223db8b66b20/pone.0236678.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/2e877bd18fe3/pone.0236678.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/b9260a9c7159/pone.0236678.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/a8a091181610/pone.0236678.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/ca729a4c0499/pone.0236678.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd53/7384661/cec01d18bb19/pone.0236678.g008.jpg

相似文献

1
Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.全面分析 CDCAs 在头颈部鳞状细胞癌中的表达和预后。
PLoS One. 2020 Jul 27;15(7):e0236678. doi: 10.1371/journal.pone.0236678. eCollection 2020.
2
Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.甲状旁腺激素相关蛋白作为口腔鳞状细胞癌的预后指标。
J Exp Clin Cancer Res. 2014 Dec 18;33(1):100. doi: 10.1186/s13046-014-0100-y.
3
Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.整合分析细胞分裂周期相关蛋白家族对胰腺腺癌的促进作用。
Int J Med Sci. 2021 Jan 1;18(3):672-684. doi: 10.7150/ijms.53243. eCollection 2021.
4
A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma.用于预测头颈部鳞状细胞癌总生存期的代谢基因特征。
Mediators Inflamm. 2020 Dec 30;2020:6716908. doi: 10.1155/2020/6716908. eCollection 2020.
5
Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis.基于生物信息学分析的头颈部鳞状细胞癌中 PLEK2 的表达及预后潜能。
Cancer Med. 2021 Sep;10(18):6515-6533. doi: 10.1002/cam4.4163. Epub 2021 Jul 30.
6
Retinol-binding protein type 1 expression predicts poor prognosis in head and neck squamous cell carcinoma.视黄醇结合蛋白 1 型表达预测头颈部鳞状细胞癌预后不良。
BMC Cancer. 2024 Oct 15;24(1):1277. doi: 10.1186/s12885-024-12565-3.
7
Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌患者自噬相关基因特征的预后相关性。
Comput Math Methods Med. 2020 Dec 28;2020:7397132. doi: 10.1155/2020/7397132. eCollection 2020.
8
High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma.GPNMB 高表达预示头颈部鳞状细胞癌预后不良。
Histol Histopathol. 2019 Jul;34(7):803-810. doi: 10.14670/HH-18-084. Epub 2019 Jan 11.
9
Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma.RUNX1 升高是人类头颈部鳞状细胞癌的预后生物标志物。
Exp Biol Med (Maywood). 2021 Mar;246(5):538-546. doi: 10.1177/1535370220969663. Epub 2020 Nov 26.
10
Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.基于综合生物信息学方法鉴定和分析头颈鳞状细胞癌相关基因。
Mol Genet Genomic Med. 2019 Aug;7(8):e857. doi: 10.1002/mgg3.857. Epub 2019 Jul 15.

引用本文的文献

1
Mechanistic insights into CDCA gene family-mediated glioblastoma progression: implications for diagnosis, prognosis, and therapeutic targeting.对CDCA基因家族介导的胶质母细胞瘤进展的机制性见解:对诊断、预后和治疗靶点的意义
Hereditas. 2025 Mar 20;162(1):43. doi: 10.1186/s41065-025-00415-6.
2
The High-Affinity IL-2 Receptor Affects White Matter Damage after Cerebral Ischemia by Regulating CD8 + T Lymphocyte Differentiation.高亲和力白细胞介素-2受体通过调节CD8 + T淋巴细胞分化影响脑缺血后的白质损伤。
J Neuroimmune Pharmacol. 2025 Jan 16;20(1):8. doi: 10.1007/s11481-025-10169-7.
3
The impact of CDCA5 expression on the immune microenvironment and its potential utility as a biomarker for PD-L1/PD-1 inhibitors in lung adenocarcinoma.

本文引用的文献

1
Human papillomavirus infection among head and neck squamous cell carcinomas in southern China.中国南方头颈部鳞状细胞癌中人乳头瘤病毒感染。
PLoS One. 2019 Sep 23;14(9):e0221045. doi: 10.1371/journal.pone.0221045. eCollection 2019.
2
Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.靶向 EZH2 通过调控 STAT3/VEGFR2 轴抑制头颈部鳞状细胞癌的上皮-间充质转化。
Int J Oncol. 2019 Nov;55(5):1165-1175. doi: 10.3892/ijo.2019.4880. Epub 2019 Sep 18.
3
The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas.
CDCA5表达对免疫微环境的影响及其作为肺腺癌中PD-L1/PD-1抑制剂生物标志物的潜在效用。
Transl Oncol. 2024 Aug;46:102024. doi: 10.1016/j.tranon.2024.102024. Epub 2024 Jun 4.
4
CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma.CDCA4作为肺腺癌患者预后不良的一种新型分子生物标志物。
Front Oncol. 2022 Sep 15;12:865756. doi: 10.3389/fonc.2022.865756. eCollection 2022.
5
Cell Division Cycle-Associated Genes Are Potential Immune Regulators in Nasopharyngeal Carcinoma.细胞分裂周期相关基因是鼻咽癌潜在的免疫调节因子。
Front Oncol. 2022 Feb 14;12:779175. doi: 10.3389/fonc.2022.779175. eCollection 2022.
6
Suppression of CDCA3 inhibits prostate cancer progression via NF‑κB/cyclin D1 signaling inactivation and p21 accumulation.CDCA3 抑制通过 NF-κB/细胞周期蛋白 D1 信号失活和 p21 积累抑制前列腺癌进展。
Oncol Rep. 2022 Feb;47(2). doi: 10.3892/or.2021.8253. Epub 2021 Dec 31.
7
Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.三阴性乳腺癌高度异质相关基因:潜在的诊断和预后生物标志物。
BMC Cancer. 2021 May 31;21(1):644. doi: 10.1186/s12885-021-08318-1.
8
Prognostic impact of LY6K and CDCA1 expression for patients with esophageal squamous cell carcinoma.LY6K和CDCA1表达对食管鳞状细胞癌患者的预后影响
Ann Gastroenterol Surg. 2020 Dec 14;5(2):194-203. doi: 10.1002/ags3.12415. eCollection 2021 Mar.
miR-205-5p/BRCA1/RAD17轴促进头颈部鳞状细胞癌的基因组不稳定。
Cancers (Basel). 2019 Sep 11;11(9):1347. doi: 10.3390/cancers11091347.
4
Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.系统的癌症-睾丸基因表达分析鉴定 CDCA5 为食管鳞癌的潜在治疗靶点。
EBioMedicine. 2019 Aug;46:54-65. doi: 10.1016/j.ebiom.2019.07.030. Epub 2019 Jul 16.
5
DNA hypomethylation promotes invasion and metastasis of gastric cancer cells by regulating the binding of SP1 to the CDCA3 promoter.DNA 低甲基化通过调节 SP1 与 CDCA3 启动子的结合促进胃癌细胞的侵袭和转移。
J Cell Biochem. 2020 Jan;121(1):142-151. doi: 10.1002/jcb.28993. Epub 2019 Jun 18.
6
CDCA5, Transcribed by E2F1, Promotes Oncogenesis by Enhancing Cell Proliferation and Inhibiting Apoptosis via the AKT Pathway in Hepatocellular Carcinoma.由E2F1转录的CDCA5通过激活AKT信号通路促进细胞增殖、抑制细胞凋亡,进而促进肝癌发生发展。
J Cancer. 2019 Apr 21;10(8):1846-1854. doi: 10.7150/jca.28809. eCollection 2019.
7
CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.CDCA2 通过体外和体内激活 AKT/CCND1 通路促进结直肠癌细胞的增殖。
BMC Cancer. 2019 Jun 13;19(1):576. doi: 10.1186/s12885-019-5793-z.
8
CDCA8 is a key mediator of estrogen-stimulated cell proliferation in breast cancer cells.CDCA8 是雌激素刺激乳腺癌细胞增殖的关键介质。
Gene. 2019 Jun 30;703:1-6. doi: 10.1016/j.gene.2019.04.006. Epub 2019 Apr 3.
9
Knockdown of cell division cycle-associated protein 4 expression inhibits proliferation of triple negative breast cancer MDA-MB-231 cells and .敲低细胞分裂周期相关蛋白4的表达可抑制三阴性乳腺癌MDA-MB-231细胞的增殖。
Oncol Lett. 2019 May;17(5):4393-4400. doi: 10.3892/ol.2019.10077. Epub 2019 Feb 26.
10
CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.CDCA3 是一种潜在的预后标志物,可促进胃癌中的细胞增殖。
Oncol Rep. 2019 Apr;41(4):2471-2481. doi: 10.3892/or.2019.7008. Epub 2019 Feb 12.